EP1651760A4 - Human blood proteins expressed in monocot seeds - Google Patents
Human blood proteins expressed in monocot seedsInfo
- Publication number
- EP1651760A4 EP1651760A4 EP03714394A EP03714394A EP1651760A4 EP 1651760 A4 EP1651760 A4 EP 1651760A4 EP 03714394 A EP03714394 A EP 03714394A EP 03714394 A EP03714394 A EP 03714394A EP 1651760 A4 EP1651760 A4 EP 1651760A4
- Authority
- EP
- European Patent Office
- Prior art keywords
- human blood
- proteins expressed
- blood proteins
- monocot seeds
- monocot
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 102000004506 Blood Proteins Human genes 0.000 title 1
- 108010017384 Blood Proteins Proteins 0.000 title 1
- 241000209510 Liliopsida Species 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/745—Blood coagulation or fibrinolysis factors
- C07K14/75—Fibrinogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/81—Protease inhibitors
- C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
- C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
- C07K14/8121—Serpins
- C07K14/8125—Alpha-1-antitrypsin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
- C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
- C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
- C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P21/00—Preparation of peptides or proteins
- C12P21/005—Glycopeptides, glycoproteins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Wood Science & Technology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- General Engineering & Computer Science (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Biotechnology (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biophysics (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Cell Biology (AREA)
- Plant Pathology (AREA)
- Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/US2003/009209 WO2004099405A1 (en) | 2003-04-11 | 2003-04-11 | Human blood proteins expressed in monocot seeds |
Publications (2)
Publication Number | Publication Date |
---|---|
EP1651760A1 EP1651760A1 (en) | 2006-05-03 |
EP1651760A4 true EP1651760A4 (en) | 2006-10-18 |
Family
ID=33434296
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
EP03714394A Withdrawn EP1651760A4 (en) | 2003-04-11 | 2003-04-11 | Human blood proteins expressed in monocot seeds |
Country Status (5)
Country | Link |
---|---|
EP (1) | EP1651760A4 (en) |
JP (1) | JP2006522585A (en) |
AU (1) | AU2003218396B2 (en) |
CA (1) | CA2525493C (en) |
WO (1) | WO2004099405A1 (en) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2551392A1 (en) * | 2003-12-23 | 2005-07-28 | Ventria Bioscience | Methods of expressing heterologous protein in plant seeds using monocot non seed-storage protein promoters |
WO2006108830A2 (en) * | 2005-04-13 | 2006-10-19 | Bayer Cropscience Sa | TRANSPLASTOMIC PLANTS EXPRESSING α 1-ANTITRYPSIN |
EP2016181B1 (en) | 2006-05-12 | 2013-04-17 | Monsanto Technology, LLC | Methods and compositions for obtaining marker-free transgenic plants |
US20110177524A1 (en) * | 2008-07-09 | 2011-07-21 | Profibrix Bv | Recombinant Fibrinogen |
CN102127164B (en) * | 2010-12-20 | 2013-01-30 | 武汉禾元生物科技有限公司 | Method for extracting recombinant human serum albumin from rice seeds |
CN102532254B (en) * | 2010-12-24 | 2015-06-24 | 武汉禾元生物科技股份有限公司 | Method for separating and purifying recombinant human serum albumin (rHSA) from rice seeds |
CN102994514B (en) * | 2012-11-07 | 2015-06-10 | 武汉禾元生物科技股份有限公司 | Method for producing, separating and purifying recombinant human antitrypsin (OsrAAT) from rice seeds |
CN103880947B (en) | 2012-12-21 | 2016-01-13 | 武汉禾元生物科技股份有限公司 | A kind of chromatography method of separating and purifying high-purity recombination human serum albumin |
EP3044320B1 (en) * | 2013-09-11 | 2020-02-19 | Impossible Foods Inc. | Secretion of heme-containing polypeptides |
MX2017014469A (en) | 2015-05-11 | 2018-04-10 | Impossible Foods Inc | Expression constructs and methods of genetically engineering methylotrophic yeast. |
CN109355291B (en) * | 2018-11-22 | 2022-01-18 | 深圳市作物分子设计育种研究院 | Identification and application of plant endosperm specific expression promoter pOsEnS93 |
US11965167B2 (en) | 2019-04-25 | 2024-04-23 | Impossible Foods Inc. | Materials and methods for protein production |
WO2024003668A1 (en) * | 2022-06-29 | 2024-01-04 | Moolec Science Limited | High expression of animal heme protein in plants |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6344600B1 (en) * | 1995-07-17 | 2002-02-05 | Meristem Therapeutics | Method for producing human hemoglobin proteins using plant cells |
WO2002064750A2 (en) * | 2001-02-14 | 2002-08-22 | Ventria Bioscience | Expression system for seed proteins |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5693506A (en) * | 1993-11-16 | 1997-12-02 | The Regents Of The University Of California | Process for protein production in plants |
-
2003
- 2003-04-11 JP JP2004571610A patent/JP2006522585A/en active Pending
- 2003-04-11 CA CA2525493A patent/CA2525493C/en not_active Expired - Lifetime
- 2003-04-11 AU AU2003218396A patent/AU2003218396B2/en not_active Ceased
- 2003-04-11 WO PCT/US2003/009209 patent/WO2004099405A1/en not_active Application Discontinuation
- 2003-04-11 EP EP03714394A patent/EP1651760A4/en not_active Withdrawn
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6344600B1 (en) * | 1995-07-17 | 2002-02-05 | Meristem Therapeutics | Method for producing human hemoglobin proteins using plant cells |
WO2002064750A2 (en) * | 2001-02-14 | 2002-08-22 | Ventria Bioscience | Expression system for seed proteins |
Non-Patent Citations (2)
Title |
---|
HUANG J ET AL: "Expression and purification of functional human alpha-1-antitrypsin from cultured plant cells", BIOTECHNOLOGY PROGRESS, XX, XX, vol. 17, no. 1, 30 December 2000 (2000-12-30), pages 126 - 133, XP002367520, ISSN: 8756-7938 * |
See also references of WO2004099405A1 * |
Also Published As
Publication number | Publication date |
---|---|
JP2006522585A (en) | 2006-10-05 |
WO2004099405A1 (en) | 2004-11-18 |
AU2003218396A1 (en) | 2004-11-26 |
AU2003218396B2 (en) | 2008-09-04 |
EP1651760A1 (en) | 2006-05-03 |
CA2525493A1 (en) | 2004-11-18 |
CA2525493C (en) | 2018-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP1594569A4 (en) | In vivo device for improving diastolic ventricular function | |
IL166809A (en) | Liquid aqueous formulations comprising human anti-tnf alpha antibodies | |
GB0321911D0 (en) | Improvements in or relating to medical devices | |
EP1651760A4 (en) | Human blood proteins expressed in monocot seeds | |
IL172511A0 (en) | Specific human antibodies | |
GB0410012D0 (en) | Open patient care unit | |
GB0306604D0 (en) | Second medical use | |
EP1603467A4 (en) | Blood vessel harvesting device | |
AU2003226899A8 (en) | Human diabetes-mediating proteins | |
EP1682572A4 (en) | Protein expression | |
EP1838728A4 (en) | Human protooncogene and protein encoded therein | |
EP1602666A4 (en) | Novel protein and its dna | |
AU2003229752A1 (en) | Human rhomboid-related protein | |
GB0321018D0 (en) | Saline preparations for clinical use | |
IL154141A (en) | In vivo device for improving diastolic ventricular function | |
IL175263A0 (en) | In vivo device for improving diastolic ventricular function | |
GB0321300D0 (en) | Protein structure and uses thereof | |
GB0417544D0 (en) | Saline preparations for clinical use | |
GB0300547D0 (en) | Medical poultices | |
PL1693378T3 (en) | Protein nmb1125 and use thereof in pharmaceutical formulations | |
GB0308979D0 (en) | Protein | |
GB0313629D0 (en) | Protein | |
GB0301253D0 (en) | Protein | |
GB0302112D0 (en) | Protein | |
GB0302773D0 (en) | Protein |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
17P | Request for examination filed |
Effective date: 20051110 |
|
AK | Designated contracting states |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR |
|
DAX | Request for extension of the european patent (deleted) | ||
A4 | Supplementary search report drawn up and despatched |
Effective date: 20060919 |
|
17Q | First examination report despatched |
Effective date: 20070319 |
|
STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
18D | Application deemed to be withdrawn |
Effective date: 20070731 |